Todd C. Davis
Chief Executive Officer at Ligand Pharmaceuticals; Director at Palvella Therapeutics; Director at Pelthos Therapeutics. Based in Jupiter, Florida.
- Rank
- 1695th of 14,644
- Companies held
- 3
- Largest holding
- LGND, 67.6% of total
- Latest SEC filing
- Jun 30, 2026
What the $84.7M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Ligand Pharmaceuticals LGND Common Stock | Directly | 199,513 | $286.94 | $57.2M | 67.6% | Form 4, Jun 30, 2026 |
| Palvella Therapeutics PVLA Common Stock | Directly | 112,547 | $145.77 | $16.4M | 19.4% | Form 3, Dec 13, 2024 |
| Pelthos Therapeutics PTHS Common Stock | Through LIGAND PHARMACEUTICALS INC | 1,500,000 | $6.99 | $10.5M | 12.4% | Form 4, Jun 11, 2026 |
| Pelthos Therapeutics PTHS Common Stock | Directly | 75,834 | $6.99 | $530K | 0.6% | Form 4, Jun 11, 2026 |
Share counts are the amounts Todd C. Davis reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1692 | Henry Schuck Chief Executive Officer, ZoomInfo Technologies. Vancouver, WA | $85.0M |
| 1693 | Elizabeth S. Campbell 10% owner, CS Disco. Little Rock, AR | $84.8M |
| 1694 | Arvind Krishna Chairman, President & CEO, International Business Machines. Falls Church, VA | $84.8M |
| 1695 | Todd C. Davis Chief Executive Officer, Ligand Pharmaceuticals. Jupiter, FL | $84.7M |
| 1696 | Robert R. Bennett Chairman of the Board, Liberty Live Holdings. New York, NY | $84.7M |
| 1697 | Jonathan M. Kemper Director, Commerce Bancshares. Kansas City, MO | $84.6M |
| 1698 | Bruce C. Cozadd Director, Jazz Pharmaceuticals | $84.5M |
Other Ligand Pharmaceuticals insiders
All LGND insiders- John L. Higgins$120MDirector. #1162 overall
- Matthew W. Foehr$74.6MInsider. #1498 overall
- Jason Aryeh$31.7MDirector. #3493 overall
- Matthew E. Korenberg$14.6MPresident & COO. #6393 overall
- Sunil Patel$13.3MInsider. #6658 overall
- John W. Kozarich$12.1MDirector. #7621 overall
Questions
How much stock does Todd C. Davis own?
Todd C. Davis holds $84,669,316 in listed stock based on SEC filings and current prices, mostly Ligand Pharmaceuticals (LGND). That ranks 1695th on the Stock Rich List.
Is this Todd C. Davis's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Todd C. Davis last buy or sell stock?
The most recent open-market trade on file is a purchase of 503 PTHS shares on Jun 11, 2026 at $28.73.